You are here

Article info

Article menu
Download PDFPDF
Therapeutics
Review
Miglustat as a therapeutic agent: prospects and caveats

Authors

  1. Correspondence to Professor Suleiman A Igdoura, McMaster University, 1280 Main St. W. LSB 335, Hamilton, Ontario L8S 4K1, Canada; igdoura{at}mcmaster.ca
View Full Text

Citation

Venier RE, Igdoura SA
Miglustat as a therapeutic agent: prospects and caveats
Journal of Medical Genetics 2012;49:591-597.

Publication history

  • Received May 23, 2012
  • Revised July 13, 2012
  • Accepted July 18, 2012
  • First published August 14, 2012.
Online issue publication 
April 27, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.